RS-61443—A new, potent immunosuppressive agent

Transplantation

Volumn 51, Issue 1, 1991, Pages 27-31

  Platz, Klaus P ^a,b   Sollinger, Hans W ^a,b   Hullett, Debra A ^a,b   Eckhoff, Devin E ^a,b   Eugui, Elsie M ^a,b   Allison, Anthony C ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b ROCHE BIOSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; DIARRHEA; DOG; GASTRITIS; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMAL; DOGS; FEMALE; GRAFT REJECTION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID; TRANSPLANTATION, HOMOLOGOUS;

EID: 0025981270     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199101000-00003     Document Type: Article

References (28)

1. Skoloski JA, Blair OC, Sartorelli AC. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5’-monophosphate dehydrogenase. Cancer Res 1986; 46: 2314.
2. Mustelin T. GTP dependence of the transduction of mitogenic signals through the T3 complex in T lymphocytes indicates the involvement of a G-protein. FEBS Lett 1987; 213: 199.
3. Ullmann B. Characterization of mutant murine lymphoma cells with altered inositate dehydrogenase activities. J Biol Chem 1983; 258: 523.
4. Lucas DL, Webster HK Wright DG. Purine metabolism in myeloid precursor cells during maturation. J Clin Invest 1983; 72: 1889.
5. Cohen MB, Maybaum J, Sadee W. Guanine nucleotide depletion and toxicity in mouse T lymphoma (S-49) cells. J Biol Chem 1981; 256: 8713.
6. Lui MS, Faderan MA, Lipenieks JJ, et al. Modulation of IMP dehydrogenase activity and guanylate metabolism by Tiazofurin. J Biol Chem 1984; 259: 5078.
7. Allison AC, Hovi T, Watts RWE, Webster ADB. The role of “de novo” purine synthesis in lymphocyte transformation. Ciba Found Symp 1977; 48: 207.
8. Allison AC, Hovi T, Watts RWE, Webster ADB. Immunological observations on patients iwth the Lesch-Nyhan syndromes and on the role of “de novo” purine synthesis in lymphocyte trans-formation. Lancet 1975; 2: 1179.
9. Franklin TJ, Cook JM. The inhibition of nucleic acid synthesis by mycophenolic acid. Biochem J 1969; 113: 515.
10. Sweeney MJ, Hoffman DH, Esterman MA. Metabolism and bio chemistry of mycophenolic acid. Cancer Res 1972; 32: 1803.
11. Lee WA, Gu L, Mikstal AR, Chu N, Leung K, Nelson PH. Bio availability improvement of mycophenolic acid through amino ester derivatization. Pharmacol Res Commun 1990; 7: 161.
12. Abrams R, Bentley M. Biosynthesis of nucleic acid purines. Arch Biochem Biophys 1959; 79: 91.
13. Abraham EP. The effect of mycophenolic acid on the growth of Staphylococcus aureus in heart broth. Biochem J 1945; 39: 398.
14. Cline JC, Nelson JD, Gerzon K, Williams RH, Delong DC. In vitro antiviral activity of mycophenolic acid and its reversal by guan- ine-type compounds. Appl Microbiol 1969; 18: 14.
15. Nelson PH, Eugui E, Wang CC, Allison AC. Synthesis and immunosuppressive activity of some side-chain variants of myco-phenolic acid. J Med Chem 1990; 33: 833.
16. Mitsui A, Suzuki S. Immunosuppressive effect of mycophenolic acid. J Antibiot (Tokyo) 1969; 22: 358.
17. Ohsugi Y, Suzuki S, Takagaki Y. Antitumor and immunosuppressive effects of mycophenolic acid derivatives. Cancer Res 1976; 36: 2933.
18. Jones EL, Epinette WW, Hackney VC, Menendez L, Rosenthal AL. Treatment of psoriasis with oral mycophenolic acid. J Invest Dermatol 1975; 65: 537.
19. Marinari R, Fleischmajer R, Schragger AH, Rosenthal AL. Myco phenolic acid in the treatment of psoriasis. Arch Dermatol 1977; 113: 930.
20. Epinette WW, Parker CM, Jones EL, Greist MC. Mycophenolic acid for psoriasis. J Am Acad Dermatol 1987; 17: 962.
21. Burlingham WJ, Grailer A, Hullett DA, Sollinger HW. Inhibition of both MLC and in vitro IgG memory response to tetanus toxoid by RS-61443. Transplantation (in press).
22. Morris RE, Grant Hoyt E, Eugui EM, Allison AC. Prolongation of rat heart allograft survival by RS-61443. Surg Forum 1989: 336.
23. Hao L, Lafferty KJ, Allison AC, Eugui EM. RS-61443 allows islet allografting and specific tolerance induction in adult mice. Trans-plant Proc 1990; 22: 876.
24. Morris RE, Wang J, Flavin T, et al. Preclinical studies in mice, rats and monkeys using mycophenolic acid and its morpholino- ethylester to control cardiac alio- and xenograft rejection. Trans-plantation (in press).
25. Eugui EM, Almquist SJ, Allison AC. Immunosuppressive effects of mycophenolic acid in vitro: role of guanosine and deoxyguano- sine nucleotide depletion. J Immunol (in press).
26. Morris RE, Grant Hoyt E, Murphys MP, Eugui EM, Allison AC. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft re-jection by selective inhibition of T- and B-cell purine synthesis. Transplant Proc (in press).
27. Wilson BS, Deanin GG, Standefer JC, Vanderjagt D, Oliver JM. Depletion guanine nucleotides with mycophenolic acid suppresses IgE receptor-mediated degranulation in rat basophilic leukemia cells. J Immunol 1989; 143: 259.
28. Kugichi K, Collart FR, Henning-Chubb C, Huberman E. Cell differentiation and altered IMP dehydrogenase expression in-duced in human T-lymphoblastoid leukemia cells by mycophenolic acid and Tiazofurin. Exp Cell Res 1990; 187: 47.